News & Events

News, industry insights and noteworthy events.

At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.

For media or press inquiries, please email us.

Contact Us

All Articles

  1. Again Life Italia Announces Partnership with Tanner Pharma Group

    CHARLOTTE, N.C., May 27, 2021 — Again Life Italia S.r.l. (“ALI”), a pharmaceutical biotechnology company headquartered in Italy, and TannerLAC UK Limited (“TannerLAC”), a wholly owned subsidiary of Tanner Pharma Group and company leader in the Latin American market, announced today the signing of a business partnership agreement for Latin America.  With a presence in…

    Read More
  2. 5 Things to Consider About Commercializing a New Drug in Latin America

    Some of the over 8,000 drugs in development are poised to be breakthrough treatments that will substantially improve or save patients’ lives. The pharmaceutical companies developing these revolutionary medications have at least two goals: ensuring their research investment is profitable and making sure the drug is available to help any person who needs it.   If your company is developing a new drug, you may be ready to achieve these goals in your existing or developed markets, but what about new ones, like Latin America and other emerging markets? If you haven’t done it before, that’s an entirely…

    Read More
  3. The Value of Real-World Data from Global Expanded Access Programs for Rare Diseases

    John Lagus, Tanner’s EVP of Business Development focusing on managed access programs, recently spoke at MarketandMarkets’ Digital Event on Orphan Drugs and Rare Diseases about the value of real-world data (RWD) from expanded access programs (EAPs) for rare diseases. Here are a few highlights from his talk.  Years ago, while in Botswana, John Lagus met a woman who offered her life savings to purchase critical medicine for her daughter. This conversation stayed with…

    Read More
  4. 3 Insights for Effective Comparator Sourcing

    Whether you’re a global pharma or a biotech start-up, every clinical trial will entail overcoming challenges with sourcing, packaging, and the logistics of clinical materials. Choosing the right partner provides you with flexibility and risk mitigation, ensuring you can choose the most cost-effective solution, and avoid delays. Here are some of the key factors to…

    Read More
  5. Increasing Access for Rare Disease Patients Globally

    Patients who suffer from rare diseases often lack access to innovative treatment options because the manufacturer of the medicine cannot justify the investment in registering and commercializing the medicine in countries where patient populations are low.  Managed Access Programs provide  manufacturers of innovative medicines for rare diseases a cost-effective option to provide patients access in countries where the medicine is not commercially available.  If a physician chooses to prescribe such…

    Read More
  6. Tanner Pharma Group Signs a Distribution Agreement for Partner Therapeutics’ Product, Leukine®

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc. (PTx), an integrated biopharmaceutical company. The agreement names Tanner Pharma Group as a distributor of Leukine® (sargramostim) in…

    Read More
  7. Tanner Pharma Group to Attend Pharmagora, PQMD, CPhI, US GCSG, and Asembia Conferences

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several healthcare conferences throughout the upcoming month of April. The team will join other global executives for the following events:  Pharmagora | April 7th…

    Read More
  8. Tanner Pharma Group To Attend Upcoming CPHI Worldwide Conference

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany. Tanner Pharma leverages more than 15 years of pharma services experience to…

    Read More
  9. The Max Foundation and Tanner Pharma Partner on Innovative Drug Distribution Model

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com Seattle, W.A. – The Max Foundation, an international non-governmental organization dedicated to increasing global access to treatment, care, and support for people living with cancer, and Tanner Pharma Group, a global pharma services company that specializes in patient access to critical medication, have partnered…

    Read More
  10. Proveca and Tanner Pharma initiate global Managed Access Program for Sialanar®

    For Immediate Release Contact: Lindsey Stevens Tanner Pharma Group 704-552-8407 lstevens@tannerpharma.com CHARLOTTE, N.C. – Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of sialorrhea, or chronic drooling, in…

    Read More
  11. Hiring of Jonathan Bracey as Managing Director – UK

    For Immediate Release Contact: Joshua Cooper Tanner Pharma Group 704.552.8408 jcooper@tannerpharma.com CHARLOTTE, N.C., December 1, 2015 – Tanner Pharma Group is pleased to announce the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015. Mr. Bracey brings two decades of management experience, making him an optimal candidate in leading the recently…

    Read More
  12. Max Global Experience: Uganda

    Tanner Pharma Group is proud to serve as the title sponsor for The Max Foundation’s 2018 “Max Global Experience: Uganda,” an expedition to raise awareness and funds for increased cancer treatment access in Africa. In August, Banks Bourne, Founder & Chairman of Tanner Pharma Group / CEO of Bourne Partners, and Rob Keel, Director of…

    Read More
  13. Tanner Pharma Group Formed From Merger of Tanner Pharmaceuticals & BurnsAdler Pharmaceuticals

    New Firm’s Complementary Divisions Provide Single-Point Solutions for Clients Seeking Clinical Trial Sourcing, Global Access Programmes and Commercialization Expertise in Challenging Global Markets  CHARLOTTE, N.C. – Tanner Pharmaceuticals, Inc., a global pharma services company that provides access to pharmaceuticals through Global Access Programmes and Clinical Trials Sourcing, and BurnsAdler Pharmaceuticals, a specialty pharmaceutical company that licenses…

    Read More

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.